Abstract
Thyroid cancer is the most common malignancy of the endocrine system and generally has a good clinical prognosis with surgical treatment and radioiodine therapy. However, a certain fraction of cases are aggressive and refractory to treatment. Mutations in the promoter of the TERT gene (TElomerase Reverse Transcriptase) are highly prevalent in aggressive thyroid carcinomas, especially in a…